Camber Capital Management

Camber Capital Management as of June 30, 2018

Portfolio Holdings for Camber Capital Management

Camber Capital Management holds 33 positions in its portfolio as reported in the June 2018 quarterly 13F filing

Company (Ticker)
Portfolio Weight
Valued At
Change in Shares
Share Count
Share Price
Spdr S&p 500 Etf (SPY) 10.4 $271M 1.0M 271.28
Allergan 6.5 $168M 1.0M 166.72
Hca Holdings (HCA) 5.3 $139M 1.4M 102.60
Biogen Idec (BIIB) 5.0 $131M 450k 290.24
Genomic Health 4.8 $124M 2.5M 50.40
Tesaro 4.3 $111M 2.5M 44.47
Bristol Myers Squibb (BMY) 4.3 $111M 2.0M 55.34
Shire 4.2 $110M 650k 168.80
Universal Health Services (UHS) 3.9 $100M 900k 111.44
Global Blood Therapeutics In 3.8 $99M 2.2M 45.20
Nektar Therapeutics (NKTR) 3.8 $98M 2.0M 48.83
Mylan Nv 3.5 $90M 2.5M 36.14
Celgene Corporation 3.1 $79M 1.0M 79.42
Tenet Healthcare Corporation (THC) 2.9 $76M 2.3M 33.57
Medicines Company 2.8 $73M 2.0M 36.70
Envision Healthcare 2.8 $73M 1.7M 44.01
Perrigo Company (PRGO) 2.6 $67M 925k 72.91
NuVasive 2.4 $63M 1.2M 52.12
Momenta Pharmaceuticals 2.4 $63M 3.1M 20.45
Atara Biotherapeutics 2.3 $60M 1.6M 36.75
Brookdale Senior Living (BKD) 2.3 $59M 6.5M 9.09
Myriad Genetics (MYGN) 2.2 $56M 1.5M 37.37
Cardiovascular Systems 2.0 $53M 1.6M 32.34
Endologix 2.0 $53M 9.3M 5.66
AMAG Pharmaceuticals 2.0 $52M 2.7M 19.50
Clovis Oncology 1.8 $46M 1.0M 45.47
K2m Group Holdings 1.7 $45M 2.0M 22.50
Mallinckrodt Pub 1.4 $36M 1.9M 18.66
Wright Medical Group Nv 1.2 $33M 1.3M 25.96
Endo International 0.9 $24M 2.5M 9.43
Eagle Pharmaceuticals (EGRX) 0.8 $20M 261k 75.66
Zymeworks 0.7 $19M 1.3M 14.78
Surgery Partners (SGRY) 0.1 $2.0M 135k 14.90